Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    03-November-2000      
Issue 204 Next Update - 14:00 UTC 08:00 EST    04-November-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Vioxx® Better Than Codeine With Acetaminophen For Pain After Dental Surgery


Study Presented At The 19th Annual Meeting Of The American Pain Society

In a new study with Vioxx® (rofecoxib), the osteoarthritis and acute pain medicine from Merck, Vioxx 50 mg significantly reduced moderate to severe acute pain after dental surgery to a greater degree compared to codeine 60 mg combined with acetaminophen 600 mg. Results of this study were presented at the 19th Annual Meeting of the American Pain Society.

The study compared a single dose of Vioxx 50 mg, the recommended dose for the treatment of acute pain in adults, to a single dose of codeine 60 mg with acetaminophen 600 mg, and to placebo. For acute pain, Vioxx 50 mg is dosed once-daily, as needed. For mild to moderately severe pain, the dose range for codeine is 15 mg to 60 mg and 300 mg to 1,000 mg for acetaminophen; doses may be repeated up to every four hours.

The 393 patients in the study (182 taking Vioxx, 180 taking codeine with acetaminophen and 31 taking placebo) experienced moderate or severe pain after the surgical removal of two or more molars, at least one of which was impacted. Patients were allowed to take an additional pain reliever during the study if needed.(1)

The study evaluated pain relief using a number of measures. The primary endpoint of the study was total pain relief over the first six hours after dosing; other measures included patients' assessment of the medicines and the use of additional pain-relieving medicine.

In this study, Vioxx reduced pain to a greater degree than codeine with acetaminophen and to a greater degree than placebo, and codeine with acetaminophen reduced pain to a greater degree than placebo, as noted below:

  • -- Overall pain relief: Vioxx was superior to codeine with acetaminophen and to placebo in providing overall pain relief over 6 hours (both p<0.001) as measured by TOPAR6, a measurement of overall pain relief. The mean TOPAR6 score(2) for Vioxx was 12.4 compared to 7.0 for codeine with acetaminophen and 3.4 for placebo (codeine with acetaminophen compared to placebo, p<0.010).
  • -- Use of additional medication: over the 24 hours after dosing, patients taking codeine with acetaminophen or placebo took additional pain relief medication sooner than patients taking Vioxx, and patients taking placebo took additional pain relief medication sooner than patients taking codeine with acetaminophen (all p<0.001). The median (50th percentile) length of time for patients to take additional medication was 1.6 hours for placebo, 2.3 hours for codeine with acetaminophen and 9.6 hours for Vioxx.
  • -- Patient assessment of study medication: significantly more patients taking Vioxx reported good, very good or excellent response six hours after initial dosing compared to patients taking codeine with acetaminophen and compared to patients taking placebo (both p<0.001). Of patients taking Vioxx, 64.6 percent reported a good to excellent response to the study medication at six hours, versus 36.4 percent of patients taking codeine with acetaminophen and 10.3 percent of patients taking placebo (codeine with acetaminophen compared to placebo, p<0.050).

This new study is the first to compare the efficacy and safety of Vioxx to codeine with acetaminophen, a medicine commonly prescribed by dentists and oral surgeons to relieve pain after dental surgery. Additional studies are underway.

Fewer patients taking Vioxx experienced nausea, vomiting in study Overall, Vioxx was well tolerated in this study, and the overall rate of side effects on Vioxx was generally similar to placebo. Significantly fewer patients taking Vioxx experienced side effects than patients taking codeine with acetaminophen (p<0.05). In particular, nausea and vomiting occurred less frequently in patients taking Vioxx than in patients taking codeine with acetaminophen. Of patients taking Vioxx, 6 percent experienced nausea compared to 25 percent of codeine with acetaminophen patients and 10 percent of placebo patients, and 4 percent of patients taking Vioxx experienced vomiting compared to 18 percent of codeine with acetaminophen patients and 6 percent of placebo patients. There were no serious adverse events in any treatment group.


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.